Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Results of Plasma Epstein-Barr Virus DNA Monitoring In Nasopharyngeal Carcinoma After Curative Treatment

NCT03973723 is registered in ClinicalTrials.gov with Taichung Veterans General Hospital as lead sponsor.

NCT NCT03973723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03973723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Results of Plasma Epstein-Barr Virus DNA Monitoring In Nasopharyngeal Carcinoma After Curative Treatment
Lead sponsor
Taichung Veterans General Hospital
Phase
Observational
Overall status
Completed
Start date
August 1, 2011
Completion date
April 30, 2019
Enrollment
441 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ebv, nasopharyngeal carcinoma, npc, radiotherapy